SHA:688578

2 stories mentioning SHA:688578Updated 26d ago

Every FINWIRES story that references SHA:688578, newest first.

Shanghai Allist Pharmaceuticals Projects H1 Profit, Revenue Growth; Shares Drop 6%

Shanghai Allist Pharmaceuticals (SHA:688578) forecasted first-half attributable net profit of 1.54 billion yuan, an increase of 46% from 1.05 billion yuan the previous year.Operating revenue is expected to rise 39% year over year to 3.31 billion yuan from 2.37 billion yuan, according to a Friday filing with the Shanghai bourse.The growth is driven by increased revenue from its core oncology products as they benefited from national medical insurance coverage and differentiated clinical advantages.Shares of the company were down 6% in recent trade.

SHA:688578

Asia111d ago

Shanghai Allist Pharmaceuticals' Attributable Profit Increases 55% in Q1

Shanghai Allist Pharmaceuticals' (SHA:688578) attributable profit rose 55% to 632.8 million yuan in the first quarter from 395.8 million yuan in the year-ago period, according to a Thursday filing with the Shanghai bourse.Earnings per share at the drug manufacturer increased to 1.41 yuan from 0.91 yuan in the prior-year period.Operating income grew 44% year over year to 1.58 billion yuan from 1.10 billion yuan.

SHA:688578

Track with the FINWIRES app suite

FolioX

Track SHA:688578 in your portfolio

WheelAI

Analyze SHA:688578 options with the wheel strategy

StockInsider

See market sentiment on SHA:688578